141 related articles for article (PubMed ID: 29113256)
1. NUDT expression is predictive of prognosis in patients with clear cell renal cell carcinoma.
Wang Y; Wan F; Chang K; Lu X; Dai B; Ye D
Oncol Lett; 2017 Nov; 14(5):6121-6128. PubMed ID: 29113256
[TBL] [Abstract][Full Text] [Related]
2. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.
Lu X; Wan F; Zhang H; Shi G; Ye D
Tumour Biol; 2016 Jan; 37(1):253-62. PubMed ID: 26198048
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma.
Wang Y; Li G; Wan F; Dai B; Ye D
Oncol Lett; 2018 Jul; 16(1):866-874. PubMed ID: 29963157
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma.
Fangning W; Chunguang M; Hailiang Z; Guohai S; Yao Z; Bo D; Yijun S; Yiping Z; Dingwei Y
J Cancer; 2017; 8(11):2010-2017. PubMed ID: 28819401
[TBL] [Abstract][Full Text] [Related]
5. SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma.
Gu W; Wang B; Wan F; Wu J; Lu X; Wang H; Zhu Y; Zhang H; Shi G; Dai B; Ye D
Oncol Lett; 2018 Apr; 15(4):4564-4570. PubMed ID: 29541226
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients.
Wan F; Wang H; Shen Y; Zhang H; Shi G; Zhu Y; Dai B; Ye D
Oncotarget; 2015 Sep; 6(29):27378-87. PubMed ID: 26317545
[TBL] [Abstract][Full Text] [Related]
8. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
[TBL] [Abstract][Full Text] [Related]
9. NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer.
Wu J; Wan F; Sheng H; Shi G; Shen Y; Lin G; Dai B; Zhu Y; Ye D
J Cancer; 2017; 8(5):852-860. PubMed ID: 28382148
[TBL] [Abstract][Full Text] [Related]
10. The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma.
Zhou Y; Wang X; Zhang W; Liu H; Liu D; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
Front Oncol; 2021; 11():630706. PubMed ID: 33968730
[TBL] [Abstract][Full Text] [Related]
11. Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma.
Jia Z; Wan F; Zhu Y; Shi G; Zhang H; Dai B; Ye D
Oncol Lett; 2018 Jun; 15(6):8669-8680. PubMed ID: 29805604
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma.
Gao Y; Qi JC; Li X; Sun JP; Ji H; Li QH
Oncol Lett; 2020 Jan; 19(1):763-770. PubMed ID: 31897192
[TBL] [Abstract][Full Text] [Related]
13. A Panel of Four-lncRNA Signature as a Potential Biomarker for Predicting Survival in Clear Cell Renal Cell Carcinoma.
Liu H; Ye T; Yang X; Lv P; Wu X; Zhou H; Zeng J; Tang K; Ye Z
J Cancer; 2020; 11(14):4274-4283. PubMed ID: 32368310
[TBL] [Abstract][Full Text] [Related]
14. Fatty Acid Synthase Correlates With Prognosis-Related Abdominal Adipose Distribution and Metabolic Disorders of Clear Cell Renal Cell Carcinoma.
Xu W; Hu X; Anwaier A; Wang J; Liu W; Tian X; Zhu W; Ma C; Wan F; Shi G; Qu YY; Zhang H; Ye D
Front Mol Biosci; 2020; 7():610229. PubMed ID: 33569391
[No Abstract] [Full Text] [Related]
15. Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
Jiang HM; Wei JH; Zhang ZL; Fang Y; Zhou BF; Chen ZH; Lu J; Liao B; Zhou FJ; Luo JH; Chen W
Int Urol Nephrol; 2016 Feb; 48(2):191-9. PubMed ID: 26589610
[TBL] [Abstract][Full Text] [Related]
16. FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients.
Li J; Jiang Z; Han F; Liu S; Yuan X; Tong J
Oncotarget; 2016 May; 7(18):25585-92. PubMed ID: 27027443
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma.
Gao L; Zhao A; Wang X
Oncol Lett; 2020 Jun; 19(6):3993-4001. PubMed ID: 32382344
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
[TBL] [Abstract][Full Text] [Related]
19. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE
Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243
[TBL] [Abstract][Full Text] [Related]
20. Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma.
Wu J; Jin S; Gu W; Wan F; Zhang H; Shi G; Qu Y; Ye D
Front Oncol; 2019; 9():152. PubMed ID: 30941304
[No Abstract] [Full Text] [Related]
[Next] [New Search]